Development of 131I-tositumomab

This publication has 20 references indexed in Scilit:

• Use of 90Y-ibritumomab tiuxetan in non-Hodgkin’s lymphoma
  Seminars in Oncology, 2005
• Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspective
  Seminars in Oncology, 2005
• Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
  Annals of Oncology, 2004
• Human antiglobulin response to foreign antibodies: therapeutic benefit?
  Cancer Immunology, Immunotherapy, 2003
• Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma
  European Journal of Nuclear Medicine and Molecular Imaging, 2002
• Binding to CD20 by Anti-B1 Antibody or F(ab') 2 is sufficient for induction of apoptosis in B-cell lines
  Cancer Immunology, Immunotherapy, 2002
• A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts
  Blood, 2001
• Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results
  Cancer Biotherapy & Radiopharmaceuticals, 2000
• Combined Modality Radioimmunotherapy with Taxol and ⁹⁰Y-LYM-1 for Raji Lymphoma Xenografts
  Cancer Biotherapy & Radiopharmaceuticals, 1998
• Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support
  New England Journal of Medicine, 1993